PATENT CLAIM ANALYSIS

Application Number: 15892057
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "235800"]

Abstract:
The present invention relates to a method of treating pre-term labour with retosiban in subjects with conditions resulting in uterine overdistension including polyhydroamnios and multiple gestation. In another aspect, the invention relates to a method of preventing pre-term labour in subjects by the prophylactic administration of retosiban.

Claim (Index 12):
The method according to  claim 11  wherein (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-(morpholin-4-yl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione is administered at a dose of between 200-500 mg/day.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 88.0
- Lexical Diversity: 1.47059
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13231211', '14946920', '12850386', '14217938', '13504681']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7986776473122209
- 35 USC 102 Novelty (BERT): 0.5650387073795873
- Combined Prediction Score: 0.7753137533189576
- Mean Citation Score: 401.7907
- Max Citation Score: 460.20587
- Similarity Product: 318.4226201412958

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test